Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

NCT01048034

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations: Department of Hematology, Aalborg University Hospital Aalborg, Denmark

Department of Hematology, Aarhus Univsersity Hospital Aarhus, Denmark

Department of Hematology, Rigshospitalet Univsersity Hospital Copenhagen, Denmark

Department of Hematology, Herlev Hospital Herlev, Denmark

View all 17 locations

View Trial Details

Completed

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

NCT00580281

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +19 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

NCT00258271

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

NCT00333840

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Novartis Investigative Site Birmingham, Alabama, United States

Novartis Investigative Site Montgomery, Alabama, United States

Novartis Investigative Site Tucson, Arizona, United States

Novartis Investigative Site Berkeley, California, United States

View all 163 locations

View Trial Details

Completed

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia

NCT00016016

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

NCT00098423

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +58 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00079378

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +27 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

NCT00301938

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +56 more
Locations: University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

NCT00470197

Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +34 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

NCT00331513

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions